Diversity & Inclusion
Health Care Enforcement and Regulation
An experienced regulatory and litigation attorney, Jennifer Bragg advises FDA-regulated companies, as well as hospitals and health care systems, facing government investigations and U.S. Food and Drug Administration (FDA) enforcement challenges. She frequently represents pharmaceutical, medical device and food companies in crisis management situations related to products that have manufacturing or quality issues, helping them navigate the myriad of matters that arise in the context of product recalls, and also counsels on compliance, advertising and promotion issues. Ms. Bragg conducts due diligence and related counseling in connection with transactions in the life sciences and health care industries. Additionally, Ms. Bragg has extensive litigation and trial experience.
Her work often involves developing strategies to help companies resolve regulatory issues to minimize litigation and enforcement risks, as well as overcome transactional hurdles. Ms. Bragg’s recent representations include, among others:
From 1998 to 2003, Ms. Bragg served in the FDA’s Office of Chief Counsel as associate chief counsel for enforcement, where she provided advice to the FDA’s Office of Criminal Investigations. During that time, she tried to verdict four criminal jury trials involving violations of the Federal Food, Drug and Cosmetic Act (FDCA) and other federal statutes. Her matters involved compounding pharmacies, unapproved pharmaceuticals, controlled substances, misbranded devices and food-related good manufacturing practices (GMP). She also was designated by the DOJ to serve as a special assistant U.S. attorney in various districts throughout the country regarding ongoing criminal investigations under the FDCA. Additionally, Ms. Bragg served as the FDA Office of Chief Counsel’s primary liaison with the Office of Criminal Investigations relating to policy issues.
Ms. Bragg has repeatedly been selected for inclusion in Chambers USA: America’s Leading Lawyers for Business. In addition, Ms. Bragg was named in The Best Lawyers in America 2013-2017, Legal 500 U.S. 2014, Lawdragon 500 Leading Lawyers in America and as a Regulatory Star in LMG Life Sciences’ 2016 rankings. She serves on the Food and Drug Law Institute’s board of directors. Ms. Bragg also has spoken on enforcement and litigation issues at numerous conferences across the United States.
In addition to her thriving practice, Ms. Bragg is a member of the firm’s Women’s Initiatives Committee, which is designed to promote the retention and advancement of women in the firm. She also is a co-chair of the firm’s hiring committee and sits on the appointments committee.
J.D., University of Maryland School of Law, 1996 (with honors)
B.A., University of Maryland, 1993
Law Clerk, Hon. William W. Wenner, Court of Special Appeals of Maryland
Member, Medical Devices Committee, The Food and Drug Law Institute
Associate Chief Counsel, U.S. Food and Drug Administration (1998-2003)